What We Are Optimising For, is a question patients ask the doctor, and doctors ask themselves! Dr Shibal Bhartiya, fellowship trained glaucoma specialist explains.
Every medical decision optimises something. What matters is being honest about what that is.
Most systems optimise for efficiency. Some optimise for throughput. Some optimise for what is measurable today, even when what matters is what happens over the next twenty years.
In my practice, the answer is different. Here is what we are actually optimising for.
Long-term vision preservation
Not short-term reassurance. Not just today’s test results.
We prioritise what protects your eyesight over decades, not weeks. A normal pressure reading today does not mean the optic nerve is safe. A clear visual field today does not mean progression is not occurring. Good glaucoma care looks further than the appointment in front of it.
Avoiding irreversible loss
Once vision is lost in glaucoma, it cannot be restored.
This makes timing, monitoring, and early intervention critical, not because glaucoma is an emergency, but because the window to protect vision is finite. Acting before damage accumulates is always more effective than responding after it has.
Stability over drama
Some systems reward late, dramatic intervention. A crisis is visible. Steady prevention is not.
I focus on early, quiet, consistent care that keeps life normal and prevents crisis. The goal is that glaucoma never becomes the thing that defines how you live. That kind of outcome does not look impressive. It just works.
Decisions you will not regret later
Every treatment recommendation involves trade-offs. We think through those trade-offs carefully, what this decision protects, what it costs, what it forecloses.
The question is not only “what is the right thing to do now?” It is “what will this patient think of this decision in fifteen years?” That longer view changes what we recommend, and when.
You understanding your own condition
An informed patient is not a difficult patient.
Understanding your diagnosis: what type of glaucoma, what stage, what your target pressure means, why monitoring matters, reduces fear, improves adherence, and produces better outcomes over time. Every question you ask is worth answering properly. Especially in a condition that requires you to continue treatment indefinitely, often without feeling any different either way.
This approach matters most for chronic, lifelong conditions like glaucoma, where the disease unfolds slowly, the damage is silent, and the decisions made early have consequences that show up decades later.
Eye care decisions are rarely urgent. But they are important.
If you are unsure whether your current plan is protecting your vision and quality of life in the long run, a structured consultation can bring clarity. And if you would like to discuss what this means for your eyes, over time, you are welcome to book an appointment.
FAQS
Frequently Asked Questions: What Good Glaucoma Care Looks Like
What should I actually expect from a glaucoma specialist?
A good glaucoma specialist does more than check your pressure and renew your drops. They establish a baseline, monitor change over time, explain what they are seeing and why it matters, and adjust treatment when the situation calls for it, not when it is too late. You should leave every appointment understanding your current status, your risk, and your plan. If you do not, ask until you do.
Why does long-term thinking matter so much in glaucoma care?
Because glaucoma is a disease that unfolds over decades, not weeks. The decisions made in the first few years: when to start treatment, what pressure target to aim for, how frequently to monitor, shape what happens twenty years later. A doctor who is only thinking about today’s appointment is not thinking about glaucoma correctly.
What does it mean to optimise for quality of life in glaucoma?
The World Glaucoma Association defines the goal of glaucoma treatment as slowing progression to a rate that is unlikely to affect quality of life during a patient’s lifetime. This means treatment decisions are not about achieving a perfect number. They are about preserving the ability to read, drive, work, move safely, and live without fear of sudden vision loss. Good care keeps glaucoma from becoming the thing that limits how you live.
Is early glaucoma treatment always better than waiting?
Early treatment reduces the lifetime risk of vision disability and slows optic nerve damage in most patients. But “early” does not mean “immediate” in every case: some patients with mildly elevated pressure and no nerve damage can be safely observed with structured monitoring. The key word is structured. Observation without a clear monitoring plan is not a safe strategy. It is a gap in care.
How do I know if my glaucoma is being managed well?
You should have a clear understanding of your diagnosis, your current pressure trend, what your OCT and visual field results show over time, and what your target pressure is. Monitoring should happen at defined intervals, not just when something feels wrong. If you have been on the same drops for years without a review of whether they are still the right choice, or if you have never had a visual field or OCT scan, these are gaps worth addressing.
What is the difference between glaucoma care that is cautious and glaucoma care that is too cautious?
Cautious glaucoma care means not operating before it is necessary, not escalating treatment without clear evidence of progression, and giving the disease time to declare itself before making irreversible decisions. Too cautious means watching a nerve deteriorate because acting feels uncomfortable, or avoiding a conversation about surgery when surgery has become the most conservative option available. The difference is whether the caution protects the patient or merely avoids a difficult decision.
Why is patient understanding so important in glaucoma management?
Glaucoma requires treatment that patients carry out themselves, drops taken at the right time, every day, for years. It requires patients to attend follow-up even when they feel completely fine. It requires patients to bring old reports, flag side effects, and ask questions when something changes. None of that happens reliably without understanding. A patient who understands why their treatment matters is a patient whose vision is protected.
Read the research articles
This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. This article was edited in April 2026.
She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.
Available on Pubmed and Google Scholar
Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care
www.drshibalbhartiya.com
+91 88826 38735
